Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Science 37 Hldgs Inc (NQ: SNCE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Science 37 Hldgs Inc < Previous 1 2 Next > Science 37 Joins Partnership in Support of White House CancerX and Cancer Moonshot May 02, 2023 Strategic partnership will leverage Science 37’s leadership in remote and hybrid clinical research to enable expansive clinical trial access for oncology patients From Science 37, Inc. Via GlobeNewswire Science 37 to Report First Quarter 2023 Financial Results on May 15, 2023 May 01, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Appoints SVP, Erica Prowisor, to Bolster Patient Recruitment Velocity, Diversity April 25, 2023 New role supports the Company’s objective to lead the industry with faster, more inclusive clinical research From Science 37, Inc. Via GlobeNewswire Science 37 Collaborates with AWS to Enable Faster, Patient-Friendly, Clinical Research April 20, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Adds New Head of Quality, Irena Lambridis April 18, 2023 New role supports the Company’s objective to be the DCT industry’s “undisputed leader” in quality From Science 37, Inc. Via GlobeNewswire Science 37 to Host Business Update Call on April 12, 2023 April 11, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality April 11, 2023 Centers of Excellence to strengthen and scale the company’s Metasite offering and accelerate its path to profitability From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) April 10, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) March 10, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results March 06, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 to Present at the Cowen 43rd Annual Health Care Conference February 23, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023 February 21, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) February 10, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Acquires Vault Health’s Life Sciences Platform To Bolster its Metasite Capabilities February 02, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) January 06, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) December 09, 2022 From Science 37, Inc. Via GlobeNewswire Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference November 30, 2022 From Science 37, Inc. Via GlobeNewswire Science 37 and BEKHealth Collaborate to Expand Patient Access Via Community Providers November 22, 2022 The partnership will enable Science 37 to directly access electronic medical record (EMR) data to find and match patients to clinical trials across its expanding community provider network, covering... From Science 37, Inc. Via GlobeNewswire Science 37 and Linical Announce Partnership to Enable Fully Decentralized and Hybrid Trials November 17, 2022 As a certified partner, Linical will leverage Science 37’s Metasite™ to provide global access to patients beyond its existing brick-and-mortar site network From Science 37, Inc. Via GlobeNewswire Science 37 Named Best in Class for Telehealth Innovation at UCSF Health Hub Digital Health Awards 2022 November 15, 2022 Science 37 is recognized for its unified platform to enable more patient-centric trials From Science 37, Inc. Via GlobeNewswire Science 37 Reports Third Quarter 2022 Financial Results November 10, 2022 From Science 37, Inc. Via GlobeNewswire Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022 November 01, 2022 From Science 37, Inc. Via GlobeNewswire Science 37 appoints Paul von Autenried to its Board of Directors October 05, 2022 Former Chief Information officer and Executive Committee member for Bristol Myers Squibb brings deep industry and technology expertise to Science 37 From Science 37, Inc. Via GlobeNewswire Science 37 to Report Second Quarter 2022 Financial Results on August 11, 2022 July 28, 2022 From Science 37, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.